Reply to 'Comment on 'Genotype-guided Warfarin Dosing Vs. Conventional Dosing Strategies: a Systematic Review and Meta-analysis of Randomized Clinical Trials' by Tse Et Al.'
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Tse G, Roever L, Wong M, Lip G, Liu T Br J Clin Pharmacol. 2018; 84(9):2165-2166.
PMID: 29984539 PMC: 6089818. DOI: 10.1111/bcp.13658.
References
1.
Tse G, Gong M, Li G, Wong S, Wu W, Wong W
. Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 2018; 84(9):1868-1882.
PMC: 6089819.
DOI: 10.1111/bcp.13621.
View
2.
Sridharan K, Sequeira R
. Comment on 'Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized clinical trials' by Tse et al. Br J Clin Pharmacol. 2018; 84(9):2162-2164.
PMC: 6089820.
DOI: 10.1111/bcp.13648.
View
3.
Tse G, Roever L, Wong M, Lip G, Liu T
. Reply to 'Comment on 'Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized clinical trials' by Tse et al.'. Br J Clin Pharmacol. 2018; 84(9):2165-2166.
PMC: 6089818.
DOI: 10.1111/bcp.13658.
View
4.
Wen M, Chang K, Lee T, Chen Y, Hung K, Chang Y
. Pharmacogenetic dosing of warfarin in the Han-Chinese population: a randomized trial. Pharmacogenomics. 2017; 18(3):245-253.
DOI: 10.2217/pgs-2016-0154.
View
5.
Gage B, Bass A, Lin H, Woller S, Stevens S, Al-Hammadi N
. Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial. JAMA. 2017; 318(12):1115-1124.
PMC: 5818817.
DOI: 10.1001/jama.2017.11469.
View